Chartwell Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$217K Hold
2,008
0.01% 411
2024
Q2
$218K Sell
2,008
-9,265
-82% -$1.09M 0.01% 410
2024
Q1
$1.49M Sell
11,273
-1,464
-11% -$183K 0.05% 320
2023
Q4
$1.55M Sell
12,737
-36,943
-74% -$4.12M 0.05% 310
2023
Q3
$5.58M Buy
49,680
+10,623
+27% +$1.35M 0.22% 175
2023
Q2
$5.69M Buy
+39,057
New +$5.31M 0.21% 185

Other funds holding ZBH

Chartwell Investment Partners's ZBH Position: Q3 2024 in Review

Chartwell Investment Partners held its Zimmer Biomet (ZBH) position steady in Q3 2024 at 2,008 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #411.

Chartwell Investment Partners first reported a position in ZBH in Q2 2023 and has held it in 6 quarters since. The position peaked at $5.69M in Q2 2023. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Chartwell Investment Partners held 2,008 shares of Zimmer Biomet worth $217K as of Q3 2024.
  • Chartwell Investment Partners left its Zimmer Biomet share count unchanged in Q3 2024.
  • Zimmer Biomet made up 0.01% of Chartwell Investment Partners's portfolio in Q3 2024, its #411 holding.
  • Chartwell Investment Partners first reported a position in Zimmer Biomet in Q2 2023 and has held it in 6 quarters since.
  • Chartwell Investment Partners's Zimmer Biomet position peaked at $5.69M in Q2 2023.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.